Carli Lehr, MD, PhD
Transplant PulmonologyPulmonology
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
FemaleAbout Carli Lehr
Biography
Carli Lehr, MD, PhD is a staff pulmonologist at the Respiratory Institute and Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, specializing in transplant medicine. She treats patients with advanced lung disease before and after lung transplantation.
Dr. Lehr is a physician scientist whose research focuses on access to transplant, organ allocation, and optimizing donor selection. Her research is supported by the National Heart, Lung, and Blood Institute and the Cystic Fibrosis Foundation. Dr. Lehr serves as a co-investigator on the Cystic Fibrosis Lung Transplant Consortium and holds the Gregory and Maureen Church endowed chair in Lung Transplantation Research.
Dr. Lehr completed medical school at The Ohio State University, internal medicine residency at Duke University, pulmonary and critical care fellowship training at Cleveland Clinic, and earned her doctoral degree in Clinical Translational Science from Case Western Reserve University.
Locations
- A Building - Crile Building
- 2049 East 100th Street, Cleveland, OH 44106
- Get Directions
- A Building - Crile Building
- 2049 East 100th Street, Cleveland, OH 44106
- Get Directions
Education & Board Certifications
Education
- Medical Education: Case Western Reserve University, 2023
- Graduate School: Case Western Reserve University School of Medicine, 2018
- Fellowship: Cleveland Clinic, 2018
- Residency: Duke University School of Medicine, 2015
- Medical Education: Ohio State University , 2012
Board Certifications
- Critical Care Medicine: American Board of Internal Medicine, 2018
- Pulmonary Disease: American Board of Internal Medicine, 2017
Awards
- Fellow of the American Society of Transplantation
- Cleveland Clinic Excellence in Teaching Award
Professional Memberships
Innovations & Patents
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-04-01, Dr. Lehr has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.